Despite an already strong run, Shanghai Junshi Biosciences Co., Ltd. (HKG:1877) shares have been powering on, with a gain of 31% in the last thirty days. The annual gain comes to 131% following the latest surge, making investors sit up and take notice.
Even after such a large jump in price, Shanghai Junshi Biosciences’ price-to-sales (or “P/S”) ratio of 12.4x might still make it look like a buy right now compared to the Biotechs industry in Hong Kong, where around half of the companies have P/S ratios above 16.3x and even P/S above 40x are quite common. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s limited.
Check out our latest analysis for Shanghai Junshi Biosciences
